IMPLANTIERBARER GLUCOSEMONITOR

European patent · EP3713473 · In force

Register entry

Publication number
EP3713473
Application number
EP18804569
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 15, 2018
Published
Sep 30, 2020
Granted
Jan 29, 2025
Protection ends at the latest
Nov 14, 2038
Next annual fee due
Nov 30, 2026
IPC classes
A61B 5/00 (2006.01)
A61B 5/145 (2006.01)
A61B 5/1455 (2006.01)
A61B 5/1459 (2006.01)
A61B 5/07 (2006.01)
Priority
EP 17306607 21.11.2017
PCT application
PCT/EP2018/081304 15.11.2018
PCT publication
WO2019/101612 31.05.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 10, 2025

    Change

    Published in Swissreg on 10.12.2025

  2. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  3. Jan 29, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.01.2025

Parties

Holder

SANOFI

Sanofi

46 avenue de la Grande Armée, 75017 Paris, FR

Inventor

KLEMM, Thomas

65926 Frankfurt, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.